Real-World Data Revealed: Getting to Know Our Experts

Run Time

10 minutes
rwd-after-dark-logo

Real-World Data After Dark is a Norstella mini-series that blends late-night talk show energy with expert conversations on real-world data (RWD) and its importance to the pharmaceutical industry, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella. In this inaugural episode, chief clinician Dr. Madeline Naylor and senior principal of RWD Solutions Lance Wolkenbrod discuss their client-focused roles, emphasizing how they partner closely with pharmaceutical companies to design high-value, data-driven solutions tailored to evolving use cases. They highlight impactful projects, including rare disease initiatives that help clients identify “needle in a haystack” patients and enable access to needed therapies, as well as oncology work in challenging indications like AML and glioblastoma, where RWD-supported clinical trials can extend patients’ lives and bring novel therapies to market. The episode also showcases the human side of the team—balancing parenthood, explaining complex RWD work in kid-friendly terms, and Lance’s passion for food and Boston’s restaurant scene—underscoring Norstella’s culture of approachable expertise and collaborative partnership with clients.

Frequently asked questions

What is “Real-World Data After Dark”?
“Real-World Data After Dark” is a Norstella video series focused on real-world data (RWD), its role in the pharmaceutical industry, and how data-driven insights help improve patient outcomes and support therapy development.
How does Norstella support pharmaceutical companies with RWD?
Norstella partners with pharmaceutical companies to develop tailored data-driven solutions, identify patient populations, support therapy development, and generate actionable clinical and commercial insights.
Why is real-world data important in rare disease research?
RWD helps identify rare disease patients who may otherwise be difficult to find, enabling pharmaceutical companies to better understand these populations and connect patients to potentially life-changing therapies.
How does Norstella help identify hard-to-reach patients?
By integrating multiple healthcare data sources and applying clinical expertise, Norstella can uncover patient populations that traditional approaches may miss.

Dive into the series

Real-world data can be complex, but it doesn’t have to be. Real-World Data After Dark blends deep insights with light late-night talk show banter. Our experts unpack complex challenges, spark new ideas, and show how real-world data shapes pharma strategy and drives better patient outcomes—with a twist.
Daniel-Chancellor
Dan Chancellor
VP, Thought Leadership, Norstella
madeline-naylor-headshot
Dr. Madeline Naylor, DHSc, MMS, CCRP
Chief Clinician, Norstella
lance-wolkenbrod-headshot
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella

Norstella Brands